Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATENCy: Aspirin vs Clopidogrel for Venous Obstruction Prevention
NCT02331511Phase 4Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2015
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in venous obstruction comparing Placebo, Aspirin and Clopidogrel (3 arms). Primary endpoint: Venous obstruction (axillary or subclavian vein) more than 50% at 3 months. Status: unknown.
02
Drugs
aspirinclopidogrel
03
Conditions
venous obstruction
Beyond the preview
Go deeper on NCT02331511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02331511.